Is MoonLake Immunotherapeutics technically bullish or bearish?
2025-10-07 12:26:17As of 3 October 2025, the technical trend for MoonLake Immunotherapeutics has changed from bullish to mildly bearish. The weekly MACD and KST indicators are both bearish, while the RSI shows a bullish signal. However, the Bollinger Bands and Dow Theory indicate a mildly bearish stance on the weekly timeframe. Daily moving averages are mildly bullish, providing some support. In terms of performance, the stock has seen a significant decline with a 1-month return of -85.43% compared to the S&P 500's 4.15%, and a year-to-date return of -84.01% versus the S&P 500's 14.18%. Overall, the current technical stance is mildly bearish, reflecting weakness across multiple indicators despite some short-term bullish signals....
Read MoreIs MoonLake Immunotherapeutics technically bullish or bearish?
2025-10-05 12:02:02As of 3 October 2025, the technical trend for MoonLake Immunotherapeutics has changed from bullish to mildly bearish. The current technical stance is mildly bearish, driven by bearish MACD readings on both weekly and monthly timeframes, along with a bearish signal from the Bollinger Bands on the weekly chart. The KST and OBV indicators also reflect a mildly bearish sentiment on the weekly, while the daily moving averages show a mildly bullish signal. The RSI is bullish on the weekly but has no signal on the monthly, indicating mixed momentum. In terms of performance, the stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -84.43% versus the S&P 500's 14.18%....
Read MoreIs MoonLake Immunotherapeutics technically bullish or bearish?
2025-09-23 11:22:40As of 19 September 2025, the technical trend for MoonLake Immunotherapeutics has changed from bullish to mildly bullish. The weekly MACD is bullish, and the monthly MACD is also bullish, supporting a positive outlook. The daily moving averages are bullish, while the weekly Bollinger Bands indicate a bullish stance and the monthly Bollinger Bands are mildly bullish. However, the KST shows a mixed signal with the weekly being bullish and the monthly mildly bearish. Dow Theory presents a mildly bearish view on the weekly timeframe but is mildly bullish on the monthly. The stock has a strong 3-year return of 653.15%, significantly outperforming the S&P 500's 70.89% over the same period. Overall, the current technical stance is mildly bullish, driven primarily by the bullish MACD and moving averages, despite some mixed signals from KST and Dow Theory....
Read MoreIs MoonLake Immunotherapeutics technically bullish or bearish?
2025-09-22 18:08:21As of 19 September 2025, the technical trend for MoonLake Immunotherapeutics has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The Bollinger Bands show a bullish stance on the weekly and mildly bullish on the monthly. Daily moving averages are mildly bullish, but the weekly Dow Theory is mildly bearish, contrasting with the monthly which is mildly bullish. In terms of returns, the stock has outperformed the S&P 500 over the past week and month, but underperformed year-to-date and over the past year. The stock has shown a remarkable 642.82% return over three years compared to the S&P 500's 70.89%. Overall, the current technical stance is mildly bullish, driven by the positive weekly indicators despite some bearish signals in the monthly metrics....
Read MoreIs MoonLake Immunotherapeutics technically bullish or bearish?
2025-09-20 20:21:04As of 12 September 2025, the technical trend for MoonLake Immunotherapeutics has changed from bullish to mildly bullish. The weekly MACD and Bollinger Bands indicate a bullish stance, while the monthly MACD is also bullish, suggesting positive momentum. However, the KST is mildly bearish on a monthly basis, and the Dow Theory shows a mixed view with a mildly bearish weekly stance and mildly bullish monthly stance. The daily moving averages are bullish, supporting the overall mildly bullish trend. In terms of performance, the stock has underperformed the S&P 500 over the past week and year, with a 1-week return of -0.26% compared to the S&P 500's 1.05%, and a 1-year return of 1.98% versus 17.14% for the index. However, it has significantly outperformed the S&P 500 over the past three years with a return of 634.87% compared to 70.41%....
Read More





